Roche. (8/29/19). "Press Release: European Commission Approves Roche’s Tecentriq in Combination with Abraxane for People with PD-L1-positive, Metastatic Triple-negative Breast Cancer". Basel. |
2019-08-29 |
Roche. (8/29/19). "Press Release: Roche Launches Ventana PD-L1 (SP142) Assay in CE Markets as First Companion Diagnostic to Identify Triple-negative Breast Cancer Patients Eligible for Treatment with Tecentriq". Basel. |
2019-08-29 |
Adrenomed AG. (8/29/19). "Press Release: Adrenomed Supervisory Board Appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, Joins the Executive Board". Hennigsdorf. |
2019-08-29 |
Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale). |
2019-08-29 |
Immatics Biotechnologies GmbH. (8/28/19). "Press Release: Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies". Houston, TX & Tübingen. |
2019-08-28 |
IBB Beteiligungsgesellschaft mbH. (8/27/19). "Pressemitteilung: Berliner Startup Krankenhaus.de sammelt Seed-Runde ein". |
2019-08-27 |
ADC Therapeutics S.A.. (8/26/19). "Press Release: ADC Therapeutics and Freenome Enter Biomarker Development Collaboration". Lausanne & South San Francisco, CA. |
2019-08-26 |
Bruker Corporation. (8/26/19). "Press Release: Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data". Berlin. |
2019-08-26 |
Bruker Corporation. (8/25/19). "Press Release: Bruker Introduces Next-Generation 80 MHz Benchtop FT-NMR System". Berlin. |
2019-08-25 |
Idorsia Ltd.. (8/23/19). "Press Release: Clinical Data on Idorsia’s Pipeline Compounds Will Be Presented at the European Society of Cardiology Congress 2019". Allschwil. |
2019-08-23 |
Themis Bioscience GmbH. (8/22/19). "Press Release: Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates". Vienna. |
2019-08-22 |
Cytosurge AG. (8/21/19). "Press Release: Cytosurge AG Announces Spin-off of Its 3D Printing Business Unit". Glattbrugg. |
2019-08-21 |
Oncorus, Inc.. (8/21/19). "Press Release: Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors". Cambridge, MA. |
2019-08-21 |
PerkinElmer, Inc.. (8/21/19). "Press Release: PerkinElmer Announces Leadership Succession Plan". Waltham, MA. |
2019-08-21 |
Araris Biotech AG. (8/20/19). "Press Release: Araris Biotech AG Closes Seed Financing Round of CHF 2.5 Million". Zurich. |
2019-08-20 |
Eppendorf AG. (8/20/19). "Press Release: Eppendorf AG with Positive First Half-year 2019. Group Sales Grow by 12.8% Percent to €378.5 million". Hamburg. |
2019-08-20 |
Bayer AG. (8/20/19). "Press Release: Bayer to Sell Its Animal Health Business Unit to Elanco for 7.6 Billion U.S. Dollars". Leverkusen. |
2019-08-20 |
Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin. |
2019-08-19 |
Genentech, Inc.. (8/19/19). "Press Release: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech". South San Francisco, CA. |
2019-08-19 |
Nabriva Therapeutics plc. (8/16/19). "Press Release: Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. |
2019-08-16 |
Roche. (8/16/19). "Press Release: FDA Approves Roche’s Rozlytrek (entrectinib) for People with ROS1-positive, MMetastatic Non-small Cell Lung Cancer and NTRK Gene Fusion-positive Solid Tumours". Basel. |
2019-08-16 |
Tecan Group Ltd.. (8/15/19). "Press Release: H1 2019 – Tecan Again Posts Significant Increase in Sales, Driven by Strong Growth in the Life Sciences Business". Männedorf. |
2019-08-15 |
H. Lundbeck A/S. (8/14/19). "Press Release: Lundbeck Appoints New EVP, People & Communication". Valby. |
2019-08-14 |
Pharming Group N.V.. (8/13/19). "Press Release: Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS". Leiden. |
2019-08-13 |
Grünenthal GmbH. (8/13/19). "Pressemitteilung: Einigung über Neuausrichtung der Forschungs- und Entwicklungsorganisation bei Grünenthal". Aachen. |
2019-08-13 |
Great Point Partners, LLC. (8/13/19). "Press Release: Great Point Partners Closes Fund III at $306 Million". Greenwich, CT. |
2019-08-13 |
Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies". Ingelheim. |
2019-08-12 |
GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA. |
2019-08-12 |
Curetis N.V.. (8/12/19). "Press Release: Curetis Retains H.C. Wainwright & Co. as Strategic Advisor". Amsterdam & Holzgerlingen. |
2019-08-12 |
Nynomic AG. (8/12/19). "Press Release: Acquisition of the Business Operations of LemnaTec GmbH Strengthens Technological Competence in the Field of Plant Phenotyping". Wedel. |
2019-08-12 |
Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim Opens Health Management Centre in China". Shanghai. |
2019-08-12 |
AC Immune S.A.. (8/12/19). "Press Release: AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases". Lausanne. |
2019-08-12 |
BlueRock Therapeutics LP. (8/8/19). "Press Release: Bayer Acquires BlueRock Therapeutics to Build Leading Position in Cell Therapy". Berlin & Cambridge, MA. |
2019-08-08 |
High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". |
2019-08-08 |
Curetis N.V.. (8/8/19). "Press Release: Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing". Vienna & Holzgerlingen. |
2019-08-08 |
Biognosys AG. (8/8/19). "Press Release: Biognosys Completes Series G Financing Round to Accelerate its Expansion into Clinical Trials Market". Schlieren. |
2019-08-08 |
IMBA – Institute of Molecular Biotechnology GmbH. (8/7/19). "Press Release: a:head bio – Launched to Transform CNS Drug Discovery". |
2019-08-07 |
NMI TT Pharmaservices. (8/6/19). "Press Release: LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development". Lincoln, NE. |
2019-08-06 |
ADC Therapeutics S.A.. (8/6/19). "Press Release: ADC Therapeutics and Sophia Genetics Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial". Lausanne. |
2019-08-06 |
Merck KGaA. (8/6/19). "Press Release: Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab". Darmstadt. |
2019-08-06 |
Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. |
2019-08-06 |
Platomics GmbH. (8/6/19). "Press Release: 7-digit Investment in Future Technology Genetic Testing". |
2019-08-06 |
IBB Beteiligungsgesellschaft mbH. (8/6/19). "Press Release: Million-euro Financing for Berlin-based Start-up Mika
". Berlin. |
2019-08-06 |
Imcyse. (8/5/19). "Press Release: Imcyse Announces Changes in Management and Board, Appoints Thomas Taapken as Executive Chairman". Liège. |
2019-08-05 |
Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg. |
2019-08-05 |
Inveox GmbH. (8/5/19). "Press Release: 17 Million for Future Cancer Diagnoses. Inveox Acquires Further Investment". Munich. |
2019-08-05 |
GNA Biosolutions GmbH. (8/5/19). "Press Release: GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium". Munich. |
2019-08-05 |
Mologen AG. (8/5/19). "Press Release: Mologen AG Announces Top Line Data of Pivotal IMPALA Study in Metastatic Colorectal Cancer. Primary Endpoint Not Met". Berlin. |
2019-08-05 |
Roche. (8/5/19). "Press Release: Roche’s Tecentriq plus Platinum-based Chemotherapy Reduced the Risk of Disease Worsening or Death in People with Previously Untreated Advanced Bladder Cancer". Basel. |
2019-08-05 |
ExpreS2ion Biotech Holding AB. (8/2/19). "Press Release: ExpreS2ion’s Licensee Institut Virion\Serion Launches the First in Vitro Diagnostic Product Based on the ExpreS2-platform". |
2019-08-02 |
Thrive Earlier Detection Corporation. (8/1/19). "Press Release: Thrive Earlier Detection Announces Appointment of David J. Daly as Chief Executive Officer". Cambridge, MA. |
2019-08-01 |
Bruker Corporation. (8/1/19). "Press Release: Bruker Reports Second Quarter 2019 Financial Results". Billerica, MA. |
2019-08-01 |
Pieris Pharmaceuticals, Inc.. (8/1/19). "Press Release: Pieris Pharmaceuticals Appoints Dr. Maya Said to its Board of Directors". Boston, MA. |
2019-08-01 |
Pieris Pharmaceuticals, Inc.. (8/1/19). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2019 Cash Position and Provides Corporate Update". Boston, MA. |
2019-08-01 |
Curetis N.V.. (8/1/19). "Press Release: Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes". Amsterdam, San Diego, CA & Holzgerlingen. |
2019-08-01 |
Immunic, Inc.. (8/1/19). "Press Release: Immunic AG Awarded Research Grant by German Federal Ministry of Education and Research in Support of the InnoMuNiCH Project". San Diego, CA. |
2019-08-01 |
Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". |
2019-07-31 |
Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin. |
2019-07-31 |
Sensyne Health plc. (7/31/19). "Press Release: Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence". |
2019-07-31 |
Sirion Biotech GmbH. (7/31/19). "Press Release: Gene and Cell Therapy Solutions Provider, Sirion Biotech Announces Record First Half 2019 Financial Results". Munich. |
2019-07-31 |
Sangamo Therapeutics, Inc.. (7/31/19). "Press Release: Sangamo Therapeutics Appoints Gary H. Loeb as Executive Vice President and General Counsel". Brisbane, CA. |
2019-07-31 |
Curetis N.V.. (7/30/19). "Press Release: Curetis and Ako Med Ink Distribution Agreement Covering Four Countries in CEE Region". Amsterdam, San Diego, CA & Holzgerlingen. |
2019-07-30 |
Quanta Dialysis Technologies Ltd.. (7/29/19). "Press Release: Quanta Raises $48 million in Series C Funding Round". Alcester, Warwickshire. |
2019-07-29 |
Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan. |
2019-07-25 |
Evotec SE. (7/25/19). "Press Release: P2X3 Antagonist Demonstrates Efficacy against Refractory Chronic Cough in Phase II (POC)". Hamburg. |
2019-07-25 |
908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA. |
2019-07-25 |
Qiagen N.V.. (7/24/19). "Press Release: Qiagen Reports Results for Second Quarter of 2019 – Updates Full-year 2019 Outlook Due to Decision to Restructure China NGS Partnership". Venlo. |
2019-07-24 |
Freenome, Inc.. (7/24/19). "Press Release: Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection". South San Francisco, CA. |
2019-07-24 |
PerkinElmer, Inc.. (7/24/19). "Press Release: PerkinElmer and EverlyWell Announce Collaboration to Expand U.S. At-Home Health Test Market". Waltham, MA & Austin, TX. |
2019-07-24 |
Cytena GmbH. (7/23/19). "Press Release: Cytena Founds Subsidiary in Taiwan". Freiburg. |
2019-07-23 |
Gain Therapeutics SA. (7/23/19). "Press Release: Gain Therapeutics SA Announces Award Notification of a €1.4M Grant Support From Eurostars-2". Lugano, Bellinzona & Gardanne. |
2019-07-23 |
Labforward GmbH. (7/23/19). "Press Release: Labforward Is Releasing an App to Support Laboratories Working in Regulated Environments. The Signature Workflows App for Labfolder ". Berlin. |
2019-07-23 |
Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig. |
2019-07-22 |
Novartis AG. (7/19/19). "Press Release: Novartis Key Multiple Sclerosis Product Gilenya Approved in China". Basel. |
2019-07-19 |
Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. |
2019-07-19 |
Gilead Sciences, Inc.. (7/19/19). "Press Release: Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis". Foster City, CA. |
2019-07-19 |
Merck KGaA. (7/18/19). "Press Release: Intermolecular Stockholders Approve Acquisition by Merck". Darmstadt. |
2019-07-18 |
Merck KGaA. (7/18/19). "Press Release: Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation". Darmstadt. |
2019-07-18 |
Boehringer Ingelheim. (7/18/19). "Press Release: Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics". Ingelheim & Seongnam. |
2019-07-18 |
Boehringer Ingelheim. (7/18/19). "Press Release: INMARK Results Suggest Prompt Treatment of IPF with Antifibrotics to Slow Disease Progression". Ingelheim. |
2019-07-18 |
Bayer AG. (7/17/19). "Press Release: Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer". Leverkusen & Boston, MA. |
2019-07-17 |
Bruker Corporation. (7/17/19). "Press Release: Bruker Comments on Block Trade Transaction". Billerica, MA. |
2019-07-17 |
Immunic, Inc.. (7/16/19). "Press Release: Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer". San Diego, CA. |
2019-07-16 |
AM-Pharma B.V.. (7/16/19). "Press Release: AM-Pharma Raises €116m ($133m) to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury". Bunnik. |
2019-07-16 |
Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London. |
2019-07-16 |
Novartis AG. (7/16/19). "Press Release: FDA Accepts File and Accelerates Review of Novartis Sickle Cell Disease Medicine Crizanlizumab (SEG101)". Basel. |
2019-07-16 |
Evogene Ltd.. (7/16/19). "Press Release: Evogene Amends Its Collaboration Agreement with Bayer to Include Genome Editing Targets". Rehovot. |
2019-07-16 |
Gemoab GmbH. (7/16/19). "Press Release: Gemoab Announces the Appointment of Oncology Expert Michael Pehl as Chief Executive Officer". Dresden. |
2019-07-16 |
Boehringer Ingelheim. (7/15/19). "Press Release: Boehringer Ingelheim Acquires Amal Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform". Ingelheim & Geneva. |
2019-07-15 |
Evotec SE. (7/15/19). "Press Release: Evotec Expands Its iPSC Platform. Acquired Assets from Ncardia AG". Hamburg. |
2019-07-15 |
Inscreenex GmbH. (7/15/19). "Press Release: Inscreenex Wins Horizon 2020 SME Instrument Phase-1 Support". Braunschweig. |
2019-07-15 |
Kymera Therapeutics Inc.. (7/15/19). "Press Release: Kymera Therapeutics Announces Leadership Transitions. Nello Mainolfi Named President of the Company – Bruce Jacobs Appointed Chief Financial Officer". Cambridge, MA. |
2019-07-15 |
Vasopharm GmbH. (7/11/19). "Press Release: Vasopharm Closes € 9.5 Million Financing Round". |
2019-07-11 |
Hookipa Pharma Inc.. (7/11/19). "Press Release: Hookipa Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers". New York, NY & Vienna. |
2019-07-11 |
Novartis AG. (7/11/19). "Press Release: Novartis, Amgen and Banner Alzheimer's Institute Discontinue Clinical Program with BACE inhibitor CNP520 for Alzheimer's Prevention". Basel. |
2019-07-11 |
Start Codon Ltd.. (7/10/19). "Press Release: Start Codon Strengthens Senior Team with Key Appointments". Cambridge. |
2019-07-10 |
Berlin Institute of Health. (7/10/19). "Press Release: A New Chapter for the Berlin Institute of Health". |
2019-07-10 |
ADC Therapeutics S.A.. (7/9/19). "Press Release: ADC Therapeutics Announces Final Close of Series E Financing Expansion". Lausanne. |
2019-07-09 |
BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz. |
2019-07-09 |
Genedata AG. (7/9/19). "Press Release: Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations". Basel. |
2019-07-09 |